Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Fred Hutchinson Cancer Research Center Identifier:
First received: April 24, 2006
Last updated: May 5, 2010
Last verified: May 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)